The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2022
Filed:
Sep. 20, 2017
Applicant:
Pneumagen Limited, Fife, GB;
Inventors:
Helen Connaris, St. Andrews, GB;
Garry Taylor, St. Andrews, GB;
Richard E. Randall, St. Andrews, GB;
Assignee:
PNEUMAGEN LIMITED, Fife, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/39 (2006.01); C07K 14/28 (2006.01); C07K 14/315 (2006.01); C12N 9/28 (2006.01); A61K 47/64 (2017.01); A61P 37/04 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/006 (2013.01); A61K 9/0043 (2013.01); A61K 47/646 (2017.08); A61P 37/04 (2018.01); C07K 14/28 (2013.01); C07K 14/3156 (2013.01); C12N 9/2417 (2013.01); C12Y 302/01018 (2013.01); A61K 2039/541 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/6068 (2013.01); A61K 2039/645 (2013.01); C07K 2319/735 (2013.01);
Abstract
The present disclosure provides novel adjuvants which may be used in combination with one or more antigens to augment, modulate or enhance a host immune response to the one or more antigens. The adjuvants are based on sialic acid binding molecules and may be combined with any type of antigen. The adjuvants may be formulated for mucosal and/or intranasal administration.